PharmaFocus Today – Page 393 – media

Vision test via voice recognition

Opternative had developed the world’s first web-based vision test via voice activation. The users can renew their prescription online using their smartphones, even if their prescription got changed. This web-based technology totally relies upon voice recognition software belonging to Microsoft, Google and IBM Watson for a safe and easy voice guided vision test. This technology understands the voice of patients and proceed them through the online vision test for the continuous medical conversation, which overall takes less than 15 minutes. The existing solution of Opternative includes both smartphone and computer; whereas, this present technology uses only the smartphone. The company was founded in 2012, which is specialized in performing vision test from anywhere at any time and get an accurate reliable prescription via online. They have created online modernized digital eye care technologies, which include detection of refractive errors and ocular health profile by the certified eye-specialists, thereby promoting enhanced user ...
- Source: drugdu
- 378
- September 11, 2018
Dyspareunia can spoil your sexual life – Act immediately!

A type of physical discomfort where the pain occurs during sexual intercourse is termed as dyspareunia. Even after intercourse, this throbbing pain may last for hours. Pain might occur due to lack of lubrication or infection in genital area. Other emotional causes like stress or history of sexual abuse may also play a major role. Females are more affected compared to males. Sometimes the condition of dyspareunia is often mistaken for lack of interest in the relationship which might cause emotional distress and greater misunderstandings. It’s high time not to feel shy and the need of the hour is to follow five treatment options listed below, to improve sexual life and emotional intimacy. Antibiotic treatment: The major cause of dyspareunia in women is pelvic inflammatory diseases (PID) which is caused due to microbial infections. Hence, the administration of proper antibiotic treatment can cure PID and dyspareunia. Psychological therapy: Psychological counseling ...
- Source: drugdu
- 767
- September 11, 2018
Drawback in PSMA PET imaging technique observed by researchers.

A study published in the September issue of The Journal of Nuclear Medicine remarked that it noticed a huge drawback in the Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) imaging technique and warned doctors who use only PSMA PET for diagnosis to be vigilant for faulty diagnosis. “It is important that nuclear medicine physicians be aware of this pitfall, as the interpretation of PSMA PET scans may have a substantial impact on therapy guidance,” said Christoph Rischpler, MD, in the department of nuclear medicine at the Technical University of Munich in Germany. For detecting prostate cancer staging and metastases in imaging, PSMA proves to be a very efficient target as it is an extremely easy-to-read enzyme, helping better diagnosis and plotting of management protocol. Recent findings, however, show that PSMA elevates in response to some benign tissue as well, duplicating findings of lymph node metastases. This could lead to ...
- Source: drugdu
- 884
- September 11, 2018
New drug formulation for opioid addiction approved by FDA.

Cassipa, a Teva Phaarmaceuticals manufactured sublingual film containing naloxone and buprenorphine in new dosage amounts, receives FDA approval on the 7th of September as a continuing therapy for opioid addiction. In a press release, the FDA announced that the buprenorphine and naloxone sublingual film, formulated in a 16 mg/4 mg dose for Cassipa, is sanctioned not only in its brand version but also in its generic edition. The two drugs in different strength combinations are also approved by the FDA. A set management protocol including psychotherapy and counseling should comprise of Cassipa post the patient is administered and stabilized with a step-ladder buprenorphine 16 mg dose of another brand. Drug Addiction Treatment Act (DATA) certified professionals only can prescribe these drugs. “There’s an urgent need to ensure access to, and wider use and understanding of, medication-assisted treatment for opioid use disorder … the FDA recently described a streamlined approach to ...
- Source: drugdu
- 1,195
- September 11, 2018
Compressor Nebulizer

A compressor nebulizer is a nebulizer driven by a compressor. Jet nebulizers which are the most commonly used nebulizers are connected by a tube to the compressor. It compresses air and pushes it into the tube which turns the liquid medicine into mist. For the successful delivery of medication to the lungs, a good quality compressor nebulizer must be used. Ddu brings the best-in-class compressor nebulizer suppliers/ manufacturers together. They are Shenzhen Homed Medical Device Co., Ltd., Vega Technologies Inc., Shenzhen Fitconn Technology Co.,ltd., SHENZHEN BI-RICH MEDICAL DEVICES CO.,LTD., Dongguan YHRT Medical Technology Co.,Ltd, AceWin Co., Ltd., and many more. As nebulizers are most frequently used in the paediatric age group, our team has included animal cartoon shaped compressor nebulizers as well. All the nebulizers are made from genuine and high-quality durable parts. They are CE/FDA certified and are have a warranty of minimum 1 year. Paediatric clinics/hospitals can purchase ...
- Source: drugdu
- 387
- September 11, 2018
Vital Signs Monitor

Electronic vital signs monitors are common place in hospitals. It has been 40 years since they have been used to monitor vital signs like heart rate, blood pressure, respiratory rate and SpO2. They are extremely important in ICUs where constant evaluation of vital signs of critical patients is crucial. Ddu (Drugdu.com) offers a vast selection of vital signs monitors. Simple electronic vital signs monitors to hi-tech portable vital signs monitors are assembled by our team. A number of manufacturers/ suppliers present their vital signs monitor on Ddu including General Meditech Inc., Shenzhen Hwatime Biological Medical Electronics Co., Ltd, Shenzhen Viatom Technology Co., Ltd, Better Life Medical, ChoiceMMed, and ShenZhen BOXYM Technology Co., Ltd.Focusing on the Checkme Lite vital signs monitor manufactured by the Shenzhen Viatom Technology Co., Ddu offers its customers with a light-weight portable heart-rate, ECG, SpO2, and blood pressure monitor. It is an easy-to-use portable medical device which ...
- Source: drugdu
- 752
- September 11, 2018
Regular daytime nap might lead to Alzheimer disease

Varied research is going on throughout the world in order to find the cause and treatment for Alzheimer’s disease. Scientists from the National Institute on Aging (NIA), Johns Hopkins Medicine and the Bloomberg School have reported that the elders who often feel sleepy during day time are three times more prone to Alzheimer’s disease. These study findings were recently published in the journal named SLEEP. Alzheimer’s disease occurs due to the development of beta-amyloid plaques in brain which results in the changes of nerve structure. The risk of this disease can be reduced by following proper exercise, diet as well as cognitive activities. Recently it was discovered that sleep pattern is also a major risk factor. Improper sleep can develop beta-amyloid protein accumulation in later stage of life. But the reason behind this mechanism is still unknown. The research team came to know the role of sleep by conducting a ...
- Source: drugdu
- 1,266
- September 10, 2018
Single dose medicine to reduce flu symptoms by one day

Influenza (flu) is a common air-borne viral infection whose symptoms include fever, body pain, cough and cold. It takes minimum five days for a complete cure, in spite of drug administration. There is no single drug against flu which can reduce the symptomatic duration in teens and adults. The scientists from the University of Virginia School of Medicine have discovered that a single dose of drug named baloxavir marboxil can quickly kill the virus and reduce the symptomatic duration by one day, with zero side effects. Baloxavir was tested in comparison with placebo and another approved drug named oseltamivir, where the time duration was comparatively proved to be lesser, via clinical trials in Japan and United States. The study findings were published in the journal named New England Journal of Medicine. Frederick G. Hayden, MD, from the University of Virginia School of Medicine, said “Baloxavir shows remarkable antiviral potency in ...
- Source: drugdu
- 353
- September 10, 2018
Discovery of new toolkit to detect musculoskeletal condition

Ageing is a normal process where the body parts especially joints, muscles and bones would become weaker. The bone density and muscle strength would deteriorate. But what is the exact benchmark that differentiates between normal condition and the diseased condition of musculoskeletal system? The scientists from the Medical Research Council-Arthritis UK Centre for Integrated Research into Musculoskeletal Ageing (CIMA) – a collaboration between Newcastle, Liverpool and Sheffield universities, have proposed a toolkit to detect the condition of joints, bones and muscles. These findings were published in the journal named Age and Ageing. Two biomarkers named CTX and PINP are the indicators of bone health condition. The bone loss or the risk of fractures can be predicted, if the levels of these biomarkers go higher especially in older females. Even the body composition, muscle mass, cartilage damage, and functional ability could be assessed. Professor John Mathers, from Newcastle University’s Institute for ...
- Source: drugdu
- 958
- September 10, 2018
Discovery of blood test to predict heart disease & stroke

The scientists from the Baker Heart and Diabetes Institute have devised a quick blood test have identified plasma lipid biomarkers which could easily predict the risk of oncoming secondary heart attack and stroke. These research findings were published in the journal named JCI Insight. This invention is currently under development. But the team had proposed to conduct the trial in Australia as a customized precision health program during the next 2-3 years. In this trial work, the physician would order this test to detect the risk of heart disease. Professor Peter Meikle, the lead investigator of this research work, said “While there are thousands of lipids in the blood, our challenge is to identify which ones best predict disease outcomes.” At first, a trial was conducted in America with the limited information based on only two lipid markers. This trial was not yet conducted anywhere. Professor Peter Meikle said, “Our ...
- Source: drugdu
- 924
- September 10, 2018

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.